Changing Regulation of Pharmaceuticals: Issues in Pricing, Intellectual Property, Trade and Ethics

Activity: Talk or presentation typesLecture and oral contribution

Behrang Kianzad - Speaker

Timo Minssen - Speaker

Today’s innovative pharmaceuticals represent a modern-day miracle, the result of tremendous public and private investment in research, development, validation of safety and efficacy, and education of patients, healthcare providers, and payers. Innovative drugs have taken on an increasingly important - many would argue indispensable - role in healthcare. With the world’s increasing reliance on the fruits of pharmaceutical R&D, issues of access and cost have come to the forefront in the current healthcare policy debate. This conference will bring together speakers from across the U.S., Europe, and Asia to confront the multifaceted array of problems and opportunities in the international effort to maximize access to innovative drugs at a cost that appropriately reflects the difficult balance between retaining adequate incentives for further innovation while at the same time allowing access to patient populations with finite abilities to pay. The conference will approach the problem from a variety of aspects, with speakers from academia addressing pertinent issues from the perspectives of law, science, business, and economics, as well as non-academic speakers from the public and private sectors and the judiciary. The international nature of the speaker lineup will facilitate an exchange of views that recognizes that the nature of the problem and the appropriate policy response varies across the globe, and provides a forum for a cross-fertilization of ideas across international borders intended to facilitate pragmatic solutions to a major challenge facing both current and future generations.
5 Apr 20196 Apr 2019

External organisation (Academic)

NameUniversity of the Pacific

    Research areas

  • excessive pricing, orphan drugs, pharmaceutical pricing, US Antitrust, EU Competition Law

Related Research outputs (1)

  1. Published

    How much is too much?- Defining the Metes and Bounds of Excessive Pricing in the Pharmaceutical Sector

    Research output: Contribution to journalJournal articleResearchpeer-review

View all »

ID: 235530478